Briumvi 150 mg concentrate for solution for infusion | medicines.ie

Company: Neuraxpharm Pharmaceuticals, S.L.
Active Ingredient: ublituximab
Strength: ublituximab: 150 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: B - prescription, may be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/23/1730/001	150 mg	L04AG14	Concentrate for solution for infusion
EU/1/23/1730/002	150 mg	L04AG14	Concentrate for solution for infusion

Licence number: EU/1/23/1730/001
Strength: 150 mg
ATC Code: L04AG14
Dosage Form: Concentrate for solution for infusion

Licence number: EU/1/23/1730/002
Strength: 150 mg
ATC Code: L04AG14
Dosage Form: Concentrate for solution for infusion

Neuraxpharm Pharmaceuticals, S.L.